BioNexus Gene Lab Corp. (BGLC)
USD 2.61
(20.28%)
USD 2.61
(20.28%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -5.79 Million USD | -181.07% |
| 2022 | -2.06 Million USD | -0.74% |
| 2021 | -2.04 Million USD | 23.17% |
| 2020 | -2.66 Million USD | -246.17% |
| 2019 | -769.64 Thousand USD | 34.68% |
| 2018 | -1.17 Million USD | -40.4% |
| 2017 | -839.14 Thousand USD | -3227380.77% |
| 2016 | -26.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -5.17 Million USD | 9.33% |
| 2024 Q1 | -5.71 Million USD | 1.47% |
| 2023 Q2 | -1.71 Million USD | 10.82% |
| 2023 FY | -5.79 Million USD | -181.07% |
| 2023 Q4 | -5.79 Million USD | 3.53% |
| 2023 Q3 | -6 Million USD | -250.75% |
| 2023 Q1 | -1.92 Million USD | 6.85% |
| 2022 FY | -2.06 Million USD | -0.74% |
| 2022 Q4 | -2.06 Million USD | -43.56% |
| 2022 Q3 | -1.43 Million USD | -9.76% |
| 2022 Q2 | -1.3 Million USD | 26.17% |
| 2022 Q1 | -1.77 Million USD | 13.41% |
| 2021 Q2 | -1.38 Million USD | 41.44% |
| 2021 Q1 | -2.36 Million USD | 11.19% |
| 2021 FY | -2.04 Million USD | 23.17% |
| 2021 Q4 | -2.04 Million USD | -26.81% |
| 2021 Q3 | -1.61 Million USD | -16.5% |
| 2020 FY | -2.66 Million USD | -246.17% |
| 2020 Q2 | -653.52 Thousand USD | 8.96% |
| 2020 Q1 | -717.85 Thousand USD | 6.73% |
| 2020 Q4 | -2.66 Million USD | -334.84% |
| 2020 Q3 | -612.69 Thousand USD | 6.25% |
| 2019 FY | -769.64 Thousand USD | 34.68% |
| 2019 Q4 | -769.64 Thousand USD | -139.45% |
| 2019 Q3 | -321.42 Thousand USD | 32.13% |
| 2019 Q2 | -473.6 Thousand USD | 12.07% |
| 2019 Q1 | -538.63 Thousand USD | 9.67% |
| 2018 Q3 | -1.34 Million USD | 0.0% |
| 2018 Q4 | -596.3 Thousand USD | 55.77% |
| 2018 Q1 | 841.69 Thousand USD | 200.3% |
| 2018 FY | -1.17 Million USD | -40.4% |
| 2017 FY | -839.14 Thousand USD | -3227380.77% |
| 2017 Q4 | -839.14 Thousand USD | 0.0% |
| 2016 FY | -26.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | -39.45 Million USD | 85.309% |
| Applied DNA Sciences, Inc. | -5.91 Million USD | 1.997% |
| Aspira Women's Health Inc. | -331 Thousand USD | -1651.04% |
| Biodesix, Inc. | 34.3 Million USD | 116.894% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -366.312% |
| bioAffinity Technologies, Inc. | -1.24 Million USD | -366.312% |
| Bionano Genomics, Inc. | 34.88 Million USD | 116.616% |
| CareDx, Inc | -47.97 Million USD | 87.919% |
| Check-Cap Ltd. | -24.75 Million USD | 76.588% |
| Castle Biosciences, Inc. | -83.53 Million USD | 93.061% |
| DarioHealth Corp. | -7.54 Million USD | 23.212% |
| Exact Sciences Corporation | 1.94 Billion USD | 100.297% |
| Fulgent Genetics, Inc. | -82.56 Million USD | 92.98% |
| Guardant Health, Inc. | 220.22 Million USD | 102.632% |
| ICON Public Limited Company | 3.56 Billion USD | 100.163% |
| IDEXX Laboratories, Inc. | 493.94 Million USD | 101.173% |
| Illumina, Inc. | 1.21 Billion USD | 100.477% |
| Intelligent Bio Solutions Inc. | -5.43 Million USD | -6.687% |
| iSpecimen Inc. | -2.14 Million USD | -169.902% |
| Standard BioTools Inc. | 46.5 Million USD | 112.463% |
| MDxHealth SA | 18.88 Million USD | 130.691% |
| 23andMe Holding Co. | -141.37 Million USD | 95.9% |
| Medpace Holdings, Inc. | -103.32 Million USD | 94.391% |
| Myriad Genetics, Inc. | 88.1 Million USD | 106.579% |
| Mainz Biomed B.V. | 349.85 Thousand USD | 1756.669% |
| ENDRA Life Sciences Inc. | -2.43 Million USD | -137.587% |
| NeoGenomics, Inc. | 269.19 Million USD | 102.153% |
| Neogen Corporation | 735.62 Million USD | 100.788% |
| Inotiv, Inc. | 382.14 Million USD | 101.517% |
| Natera, Inc. | -200.1 Million USD | 97.104% |
| OpGen, Inc. | 11.89 Million USD | 148.739% |
| OPKO Health, Inc. | 230.68 Million USD | 102.513% |
| Psychemedics Corporation | 334 Thousand USD | 1835.312% |
| Prenetics Global Limited | -43.33 Million USD | 86.626% |
| Prenetics Global Limited | -43.33 Million USD | 86.626% |
| Precipio, Inc. | -386 Thousand USD | -1401.539% |
| Personalis, Inc. | -8.02 Million USD | 27.749% |
| RadNet, Inc. | 1.14 Billion USD | 100.505% |
| Sera Prognostics, Inc. | -2.02 Million USD | -186.644% |
| Sotera Health Company | 2.02 Billion USD | 100.286% |
| Neuronetics, Inc. | 2.79 Million USD | 307.22% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 62.209% |
| Star Equity Holdings, Inc. | -15.33 Million USD | 62.209% |
| Trinity Biotech plc | 63.73 Million USD | 109.094% |
| T2 Biosystems, Inc. | 33.8 Million USD | 117.143% |
| Twist Bioscience Corporation | -192.4 Million USD | 96.988% |
| Exagen Inc. | -12.77 Million USD | 54.62% |